Study of some common conventional excipients

Study of some common
Conventional excipients
Pharmaceutical Excipients’ Monographs

Content
Lactose
Starch
Magnesium stearate
Talc
Bentonite
Glycerol
Paraffins
Sodium Lauryl Sulphate
Sodium saccharin
Tweens and Spans
Arachis oil
Wool fat
Glyceryl mono stearate

Lactose
(Lactose,
Anhydrous)
• Anhydrous lactose occurs as white
to off-white crystalline particles or
powder.
• Several different brands of
anhydrous lactose are commercially
available which contain anhydrous
b-lactose and anhydrous a-lactose.
• Anhydrous lactose typically
contains 70–80% anhydrous b-
lactose and 20–30% anhydrous a-
lactose.

Lactose (Lactose,
Anhydrous)
• Chemical nature
O-b-D-Galactopyranosyl-(1→4)-
b-D-glucopyranose
• CAS [63-42-3]
• C12H22O11 (342.30)

Lactose
(Lactose,
Anhydrous)
Functional Category
• Directly compressible tablet
excipient; dry powder inhaler
carrier; lyophilization aid; tablet
and capsule diluent; tablet and
capsule filler.

Lactose
(Lactose,
Anhydrous)
Applications in Pharmaceutical
Formulation or Technology/ Role
• Anhydrous lactose is widely used in
direct compression tableting
applications, and as a tablet and
capsule filler and binder.
• Anhydrous lactose can be used with
moisture-sensitive drugs due to its
low moisture content. It may also
be used in intravenous injections.

Lactose
(Lactose,
Anhydrous)
Method of Manufacture
• There are two anhydrous forms of lactose: a-lactose
and b-lactose.
• The temperature of crystallization influences the
ratio of a- and b-lactose.
• The anhydrous forms that are commercially available
may exhibit hygroscopicity at high relative humilities.
• Anhydrous lactose is produced by roller drying a
solution of lactose above 93.58C. The resulting
product is then milled and sieved.
• Two anhydrous a-lactoses can be prepared using
special drying techniques: one is unstable and
hygroscopic; the other exhibits good compaction
properties.

Lactose
(Lactose,
Anhydrous)
Incompatibilities
• Lactose anhydrous is incompatible with strong
oxidizers. When mixtures containing a hydrophobic
leukotriene antagonist and anhydrous lactose or
lactose monohydrate were stored for six weeks at
408C and 75% RH, the mixture containing
anhydrous lactose showed greater moisture uptake
and drug degradation.
• Studies have also shown that in blends of roxifiban
acetate (DMP-754) and lactose anhydrous, the
presence of lactose anhydrous accelerated the
hydrolysis of the ester and amidine groups.
• Lactose anhydrous is a reducing sugar with the
potential to interact with primary and secondary
amines (Maillard reaction) when stored under
conditions of high humidity for extendedperiods.

Lactose
(Lactose,
Anhydrous)
Safety
• Lactose is widely used in pharmaceutical
formulations as a diluent and filler-binder in
oral capsule and tablet formulations.
• It may also be used in intravenous
injections.
• Adverse reactions to lactose are largely due
to lactose intolerance, which occurs in
individuals with a deficiency of the
intestinal enzyme lactase, and is associated
with oral ingestion of amounts well over
those found in solid dosage forms.
Regulatory Status
• GRAS listed

Description
• Starch occurs as an odorless and tasteless, fine, white to off-white
powder.
• It consists of very small spherical or ovoid granules or grains whose
size and shape are characteristic for each botanical variety

Source
• Starch is isolated from vegetable sources.
• Pure starch should only contain traces of foreign matter (e.g. tissue
fragments) and no traces of starches other than from the declared
botanical origin.
• Inside their crystalline structure, starch particles contain smaller quantities
of lipids (0–0.8%) and proteins (0–0.5%).
• The contents are relatively stable and typical for each starch variety.
• Starches from different plant sources differ in their amylose/amylopectin
ratio
• Differences in the physical properties of the various starches mean that
they are not automatically interchangeable in a given pharmaceutical
application

Chemical nature
• Chemical Name and CAS Registry Number: Starch [9005-25-8]
• Empirical Formula (C6H10O5)n where n = 300–1000.
• Molecular Weight: 50 and 500 million Da (depending upon souurce)
• Starch consists of linear amylose and branched amylopectin, two
polysaccharides based on a-(D)-glucose.
• Both polymers are organized in a semicrystalline structure, and in the
starch granule, amylopectin forms the crystalline portion.

Segment of
amylopectin
(starch)
Starch is composed of amylose and
amylopectin, polymers of glucose
connected by
α-(1-4)-glycosidic linkages (in contrast to
cellulose β-1,4 linkages)

Functional Category
• Tablet and capsule disintegrant
• Tablet binder;
• Thickening agent

Pharmaceutical application
• As a diluent, starch is used for the preparation of standardized
triturates of colorants, potent drugs, and herbal extracts, facilitating
subsequent mixing or blending processes in manufacturing
operations.
• Starch is one of the most commonly used tablet disintegrants at
concentrations of 3–25% w/w; a typical concentration is 15%
• Starch is also used in dry-filled capsule formulations for volume
adjustment of the fill matrix
• Starches are useful carriers for amorphous drug preparations, such as
pellets with immediate or delayed drug release property

Incompatibilities
• Starch is incompatible with strongly oxidizing substances.
• Colored inclusion compounds are formed with iodine

Source & Method of Manufacture
• Starch is extracted from plant sources with specific processes
according to the botanical origin like corn (Zea mays), potato
(Solanum tuberosum)
• Typical production steps are steeping/soak (corn), wet milling (corn,
potato), dry milling (wheat), or sieving and physical separation using
hydrocyclones.
• The last production step is usually a centrifugal separation from the
starch slurry followed by drying with hot air.
• The starch separation process may use sulfur dioxide or peroxides as
a processing aid, improving the separation process and the microbial
quality of the final product

Safety
• Starch is an edible food substance, considered a food ingredient and
not a food additive. It is regarded as an essentially nontoxic and
nonirritant material.
• Starch is therefore widely used as an excipient in pharmaceutical
formulations

Regulatory Status
• GRAS listed.
• Included in the FDA Inactive Ingredients Database (buccal tablets, oral
capsules, powders, suspensions and tablets; topical preparations; and
vaginal tablets).
• Included in nonparenteral medicines licensed in the UK.
• Included in the Canadian List of Acceptable Non-medicinal
Ingredients.

Description
• Magnesium stearate is a very fine, light white, precipitated or milled,
impalpable powder of low bulk density, having a faint odor of stearic
acid and a characteristic taste.
• The powder is greasy to the touch and readily adheres to the skin

Properties
• Chemical Name: Octadecanoic acid magnesium salt
• Synonym: Dibasic magnesium stearate, magnesium distearate
• CAS Registry Number: [557-04-0]
• Empirical Formula: C36H70MgO4
• Molecular Weight: 591.24
• Functional Category: Tablet and capsule lubricant

Functional Category
• Tablet and capsule lubricant

Applications in Pharmaceutical Formulation
• Magnesium stearate is widely used in cosmetics, foods, and
pharmaceutical formulations.
• It is primarily used as a lubricant in capsule and tablet manufacture at
concentrations between 0.25% and 5.0% w/w.
• It is also used in barrier creams (A barrier cream is a topical
formulation used in industrial applications and as a cosmetic to place
a physical barrier between the skin and contaminants that may
irritate the skin)

• Magnesium stearate is prepared by either method
• By the interaction of aqueous solutions of magnesium
chloride with sodium stearate
• By the interaction of magnesium oxide, hydroxide, or
carbonate with stearic acid at elevated temperatures

Incompatibilities
• Incompatible with strong acids, alkalis, and iron salts.
• Avoid mixing with strong oxidizing materials.
• Magnesium stearate cannot be used in products containing aspirin,
some vitamins, and most alkaloidal salts.

Safety
• Magnesium stearate is widely used as a pharmaceutical excipient and
is generally regarded as being nontoxic following oral administration.
• However, oral consumption of large quantities may produce a laxative
effect or mucosal irritation.
• LD50 (rat, inhalation): >2 mg/L(2)
• LD50 (rat, oral): >10 g/kg

Regulatory Acceptance
• GRAS listed.
• Accepted as a food additive in the USA and UK.
• Included in the FDA Inactive Ingredients Database (oral capsules,
powders, and tablets; buccal and vaginal tablets; topical preparations
intravitreal implants and injections).
• Included in non-parenteral medicines licensed in the UK.
Ingredients.

Handling Precautions
• Eye protection and gloves are recommended.
• Excessive inhalation of magnesium stearate dust may cause upper
respiratory tract discomfort, coughing, and choking.
• Magnesium stearate should be handled in a well-ventilated
environment; a respirator is recommended.

Comments
• Magnesium stearate is hydrophobic and may retard the dissolution
of a drug from a solid dosage form; the lowest possible concentration
is therefore used in such formulation
• Reduction in dissolution caused by the effects of magnesium stearate
in some cases can be overcome by including a highly swelling
disintegrant in the formulation

Description
• Bentonite is a crystalline, claylike mineral, and is available as an
odorless, pale buff, or cream to grayish-colored fine powder, which is
free from grit.
• It consists of particles about 50–150 mm in size along with numerous
particles about 1–2 mm.
• Microscopic examination of samples stained with alcoholic methylene
blue solution reveals strongly stained blue particles.
• Bentonite may have a slight earthy taste.

Chemical Name and CAS Registry Number
• Bentonite [1302-78-9]

Empirical Formula and Molecular Weight
• Al2O3.4SiO2 H2O, 359.16
• Bentonite is a native colloidal hydrated Aluminum silicate consisting
mainly of montmorillonite, Al2O34SiO2 H2O; it may also contain
calcium, magnesium, and iron.

Properties
• Acidity/alkalinity pH = 9.5–10.5 for a 2% w/v aqueous suspension
• Bentonite is hygroscopic.
• Practically insoluble in ethanol, fixed oils, glycerin, propan-2-ol, and
water.
• Bentonite swells to about 12 times its original volume in water, to
form viscous homogeneous suspensions, sols, or gels depending upon
the concentration.

• Bentonite is a native, colloidal, hydrated aluminum silicate, found in
regions of Canada and the USA.
• The mined ore is processed to remove grit and non-swelling materials
so that it is suitable for pharmaceutical applications.

Functional Category
• Suspending agent
• Viscosity increasing agent
• Adsorbent
• Stabilizing agent

• Bentonite is a naturally occurring hydrated aluminum silicate used
primarily in the formulation of suspensions, gels, and sols, for topical
pharmaceutical applications.
• It is also used to suspend powders in aqueous preparations and to
prepare cream bases containing oil-in-water emulsifying agents
• E.g. Calamine lotion

Incompatibilities
• Aqueous bentonite suspensions retain their viscosity above pH 6, but are
precipitated by acids.
• Acid-washed bentonite does not have suspending properties.
• The addition of alkaline materials, such asmagnesium oxide, increases gel
formation.
• Addition of significant amounts of alcohol to aqueous preparations will
precipitate bentonite
• Bentonite particles are negatively charged and flocculation occurs when
electrolytes or positively charged suspensions are added
• The antimicrobial efficacy of cationic preservatives may be reduced in
aqueous bentonite suspensions, but nonionic and anionic preservatives are
unaffected
• Bentonite does not swell in organic solvents

Safety
• Bentonite is mainly used in topical pharmaceutical formulations but
has also been used in oral pharmaceutical preparations, food
products, and cosmetics.
• Following oral administration, bentonite is not absorbed from the
gastrointestinal tract.
• Bentonite is generally regarded as a nontoxic and non-irritant
material

Regulatory Status
• Accepted in Europe as a food additive in certain applications.
• Included in the FDA Inactive Ingredients Database (oral capsules,
tablets and suspensions, topical suspensions, controlled release
transdermal films and vaginal suppositories).
• Included in non-parenteral medicines licensed in the UK.
Ingredients

Description
• Glycerin is a clear, colorless, odorless, viscous, hygroscopic liquid; it
has a sweet taste, approximately 0.6 times as sweet as sucrose

• Propane-1,2,3-triol [56-81-5]

• C3H8O3 92.09

• Glycerin is mainly obtained from oils and fats as a by-product in the
manufacture of soaps and fatty acids.
• It may also be obtained from natural sources by fermentation of, for
example, sugar beet molasses in the presence of large quantities of
sodium sulfite.
• Synthetically, glycerin may be prepared by the chlorination and
saponification of propylene

Functional Category
• Humectant
• Tonicity agent (non-ionic)
• Emollient
• Cosolvent/ solvent
• Antimicrobial preservative
• Plasticizer
• Sweetening agent

• Glycerin is used in a wide variety of pharmaceutical formulations
including oral, otic, ophthalmic, topical, and parenteral preparations;
• In topical pharmaceutical formulations and cosmetics, glycerin is used
primarily for its humectant and emollient properties.
• Glycerin is used as a solvent or cosolvent in creams and emulsions.
• Glycerin is additionally used in aqueous and nonaqueous gels and
also as an additive in patch applications

• In parenteral formulations, glycerin is used mainly as a solvent and
cosolvent oral solutions, glycerin is used as a solvent, sweetening
agent, antimicrobial preservative, and viscosity-increasing agent.
• It is also used as a plasticizer and in film coatings.
• Glycerin is used as a plasticizer of gelatin in the production of soft-
gelatin capsules and gelatin suppositories.
• Glycerin is employed as a therapeutic agent in a variety of clinical
applications, and is also used as a food additive

Stability and Storage Conditions
• Glycerin is hygroscopic. Pure glycerin is not prone to oxidation by the
atmosphere under ordinary storage conditions, but it decomposes on
heating with the evolution of toxic acrolein.
• Mixtures of glycerin with water, ethanol (95%), and propylene glycol
are chemically stable.

Incompatibilities
• Glycerin may explode if mixed with strong oxidizing agents such as
chromium trioxide, potassium chlorate, or potassium permanganate.

Safety
• Glycerin occurs naturally in animal and vegetable fats and oils that are
consumed as part of a normal diet.
• Glycerin is readily absorbed from the intestine and is either
metabolized to carbon dioxide and glycogen or used in the synthesis
of body fat
• Glycerin is used in a wide variety of pharmaceutical formulations
including oral, ophthalmic, parenteral, and topical preparations.
• Adverse effects are mainly due to the dehydrating properties of
glycerin.

Description
• Talc is a very fine, white to grayish-white, odorless, impalpable,
unctuous, crystalline powder.
• It adheres readily to the skin and is soft to the touch and free from
grittiness

• Talc [14807-96-6]

• Talc is a purified, hydrated, magnesium silicate, approximating to the
formula Mg6(Si2O5)4(OH)4.
• It may contain small, variable amounts of aluminum silicate and iron.

Functional Category
• Tablet and capsule diluent; lubricant; Glidant
• Anticaking agent

Applications in Pharmaceutical Formulation or
Technology
• Talc was once widely used in oral solid dosage formulations as a lubricant
and diluent, although today it is less commonly used.
• However, it is widely used as a dissolution retardant in the development
of controlled-release products
• Talc is also used as a lubricant in tablet formulations;
• In a novel powder coating for extended-release pellets;
• An adsorbent in dusting powder, although it should not be used to dust
surgical gloves
• Talc is a natural material; it may therefore frequently contain
microorganisms and should be sterilized when used as a dusting powder

• Talc is a stable material and may be sterilized by heating at 160 C for
not less than 1 hour.
• It may also be sterilized by exposure to ethylene oxide or gamma
irradiation.
• Talc should be stored in a well-closed container in a cool, dry place.

Source
• Talc is a naturally occurring hydropolysilicate mineral found in many
parts of the world including Australia, China, Italy, India, France, and
the USA
• The purity of talc varies depending on the country of origin.
• Italian types are reported to contain calcium silicate as the
contaminant;
• Indian types contain aluminum and iron oxides;
• French types contain aluminum oxide;
• American types contain calcium carbonate (California)

• Naturally occurring talc is mined and pulverized (crushed) before
being subjected to flotation processes to remove various impurities
such as asbestos (tremolite); carbon; dolomite; iron oxide; and
various other magnesium and carbonate minerals.
• Following this process, the talc is finely powdered,
• Then treated with dilute hydrochloric acid,
• Washed with water, and then dried.

Safety
• Talc is not absorbed systemically following oral ingestion and is
therefore regarded as an essentially nontoxic material.
• However, intranasal or intravenous abuse of products containing talc
can cause granulomas in body tissues, particularly the lungs it should
not be used to dust surgical gloves
• Talc contaminated with asbestos has been proved to be carcinogenic
in humans

Regulatory Status
• Accepted for use as a food additive in Europe. Included in the FDA
• Inactive Ingredients Database (buccal tablets; oral capsules and
tablets; rectal and topical preparations).
• Included in nonparenteral medicines licensed in the UK. Included in
the Canadian List of Acceptable Non-medicinal Ingredients

Tweens (80, 20)
• Synonym: Polysorbate 80 , Polysorbate 20
• Chemical name: Polyoxyethylene 80 sorbitan monooleate
Polyoxyethylene 20 sorbitan monooleate
• Empherical formula: C64H124O26 , C58H114O26

Description
• Polysorbates have a characteristic odor and somewhat bitter taste.
• Colour: Yellow oily liquid

Properties
• HLB value
• Tween 80 → 15
• Tween 20 → 16.7
• Acidity/alkalinity pH = 6.0–8.0 for a 5% w/v aqueous solution.

Functional Category
• Dispersing agent
• Emulsifying agent
• Non-ionic surfactant
• Solubilizing agent
• Wetting agent.

Technology
• Polysorbates containing 20 units of oxyethylene are hydrophilic
nonionic surfactants that are used widely as emulsifying agents in the
preparation of stable oil-in-water pharmaceutical emulsions.
• They may also be used as solubilizing agents for a variety of
substances including essential oils and oil-soluble vitamins, and as
wetting agents in the formulation of oral and parenteral suspensions.

Incompatibilities
• Discoloration and/or precipitation occur with various substances,
especially phenols, tannins, tars, and tarlike materials.
• The antimicrobial activity of paraben preservatives is reduced in the
presence of polysorbates

• Polysorbates are prepared from sorbitol in a three-step process.
• Water is initially removed from the sorbitol to form a sorbitan (a cyclic
sorbitol anhydride).
• The sorbitan is then partially esterified with a fatty acid, such as oleic
or stearic acid, to yield a hexitan ester.
• Finally, ethylene oxide is chemically added in the presence of a
catalyst to yield the polysorbate

Safety
• Polysorbates are widely used in cosmetics, food products, and oral,
• parenteral and topical pharmaceutical formulations, and are generally
regarded as nontoxic and nonirritant materials.
• There have been occasional reports of hypersensitivity to
polysorbates following their topical and intramuscular use.
• The WHO has set an estimated acceptable daily intake for
polysorbates 20, 40, 60, 65, and 80, calculated as total polysorbate
esters, at up to 25 mg/kg body-weight
• Polysorbate 20 Moderate toxicity by IP and IV routes LD50 (mouse, IV):
1.42 g/kg)

Regulatory Status
• Polysorbates 60, 65, and 80 are GRAS listed.
• Polysorbates 20, 40, 60, 65, and 80 are accepted as food additives in
Europe

• Polysorbates are stable to electrolytes and weak acids and bases;
gradual saponification occurs with strong acids and bases.
• Polysorbates are hygroscopic
• Polysorbates should be stored in a well-closed container, protected
from light, in a cool, dry place.

Spans Sorbitan Esters (Sorbitan
Fatty Acid Esters)

Chemical name & Formula
• Synonym:
• Span 80→ Sorbitan monooleate,
• Sorbitan monoisostearate→ Span 20
• Chemical name: (Z)-Sorbitan mono-9- octadecenoate, Sorbitan
monoisooctadecanoate
• Formula: C24H44O6, C24H46O6

Description
• Sorbitan esters occur as cream- to amber-colored liquids or solids
with a distinctive odor
• Sorbitan monooleate → Yellow viscous liquid (HLB 4.7)
• Sorbitan monoisostearate→ Yellow viscous liquid (HLB 4.3)

Functional Category
• Dispersing agent
• Nonionic surfactant
• Wetting agent

Technology
• Sorbitan esters are widely used in cosmetics, food products, and
pharmaceutical formulations as lipophilic nonionic surfactants.
• They are mainly used in pharmaceutical formulations as emulsifying
agents in the preparation of creams, emulsions, and ointments for
topical application.
• When used alone, sorbitan esters produce stable water-in-oil
emulsions and microemulsions, but are frequently used in
combination with varying proportions of a polysorbate to produce
water-in-oil or oil-in-water emulsions or creams of varying
consistencies, and also in self-emulsifying drug delivery systems for
poorly soluble compounds.

• Sorbitol is dehydrated to form a hexitan (1,4-sorbitan), which is then
esterified with the desired fatty acid

Safety
• Sorbitan esters are widely used in cosmetics, food products, and oral and
topical pharmaceutical formulations, and are generally regarded as
nontoxic and nonirritant materials.
• However, there have been occasional reports of hypersensitive skin
reactions following the topical application of products containing
sorbitan.
• The WHO has set an estimated acceptable daily intake limit of sorbitan as
25 mg/kg body weight calculated as total sorbitan esters

Regulatory Status
• Certain sorbitan esters are accepted as food additives in the UK.
• Sorbitan esters are included in the FDA Inactive Ingredients Database
(inhalations; IM injections; ophthalmic, oral, topical, and vaginal
preparations).

Description
• Glyceryl monostearate is a white to cream-colored, wax-like solid in
the form of beads, flakes, or powder.
• It is waxy to the touch and has a slight fatty odor and taste
• HLB value 3.8

Chemical Name & Formula
• Chemical Name : Octadecanoic acid, monoester with 1,2,3-
propanetriol
• Synonym: Imwitor 900;
• Formula: C21H42O4

Functional Category
• Emollient
• Stabilizing agent
• Sustained-release agent
• Tablet and capsule lubricant.

Technology
• The many varieties of glyceryl monostearate are used as nonionic
emulsifiers, stabilizers, emollients, and plasticizers in a variety of food,
pharmaceutical, and cosmetic applications.
• It acts as an effective stabilizer, that is, as a mutual solvent for polar
and nonpolar compounds that may form water-in-oil or oil-in-water
emulsions.
• These properties also make it useful as a dispersing agent for pigments
in oils or solids in fats, or as a solvent for phospholipids, such as
lecithin.
• Glyceryl monostearate has also been used in a novel fluidized hot-melt
granulation technique for the production of granules and tablets.
• Glyceryl monostearate is a lubricant for tablet manufacturing and may
be used to form sustained-release matrices for solid dosage

• If stored at warm temperatures, glyceryl monostearate increases in
acid value upon aging owing to the saponification of the ester with
trace amounts of water.
• Effective antioxidants may be added, such as butylated
hydroxytoluene and propyl gallate.
• Glyceryl monostearate should be stored in a tightly closed container
in a cool, dry place, and protected from light.

Incompatibilities
• The self-emulsifying grades of glyceryl monostearate are incompatible
with acidic substances.

• Glyceryl monostearate is prepared by the reaction of glycerin with
triglycerides from animal or vegetable sources, producing a mixture of
monoglycerides and diglycerides.
• The diglycerides may be further reacted to produce the 90%
monoglyceride grade.
• Another process involves reaction of glycerol with stearoyl chloride.

Safety
• Glyceryl monostearate is widely used in cosmetics, foods, and oral
and topical pharmaceutical formulations, and is generally regarded as
a nontoxic and nonirritant material.
• LD50 (mouse, IP): 0.2 g/kg
• Regulatory Status:
• GRAS listed.
• Included in the FDA Inactive Ingredients Database (oral capsules and tablets;
ophthalmic, otic, rectal, topical, transdermal, and vaginal preparations).

Paraffins
Liquid: Heavy /Light Mineral
oil
Semi solid: Soft
(Yellow/White)
Solid: Hard Paraffin

Liquid Paraffin (Heavy, Light)
• Synonym: Mineral oil
• Empirical Formula and Molecular Weight: Mineral oil is a mixture of
refined liquid saturated aliphatic (C14–C18) and cyclic hydrocarbons
obtained from petroleum.
• Light mineral oil is a mixture of refined liquid saturated hydrocarbons
obtained from petroleum.
• It is less viscous and has a lower specific gravity than heavy mineral
oil.

Description
• Mineral oil is a transparent, colorless, viscous oily liquid, without
fluorescence in daylight.
• It is practically tasteless and odorless when cold, and has a faint odor
of petroleum when heated

Functional Category
• Emollient; (Emollient definition is - making soft or supple; also :
soothing especially to the skin or mucous membrane)
• Lubricant
• Oleaginous vehicle
• Solvent
• Vaccine adjuvant.

or Technology (Mineral oil: Heavy)
• Mineral oil is used primarily as an excipient in topical pharmaceutical
formulations, where its emollient properties are exploited as an
ingredient in ointment bases
• It is additionally used in oil-in-water emulsions,
• lubricant in capsule and tablet formulations, in suppositories –mold
• preparation of microspheres

Technology (Mineral oil: light)
• Light mineral oil is used in applications similar to those of mineral oil.
• It is used primarily as an excipient in topical pharmaceutical formulations
where its emollient properties are exploited in ointment bases
• It is also used in ophthalmic formulations.
• Light mineral oil is additionally used in oil-in water and polyethlylene
glycol/glycerol emulsions
• As a solvent and lubricant in capsules and tablets; as a solvent and
penetration enhancer in transdermal preparations
• As the oily medium used in the microencapsulation of many drugs
• Light mineral oil is also used in cosmetics and certain food products.

• Mineral oil undergoes oxidation when exposed to heat and light.
• Oxidation begins with the formation of peroxides, exhibiting an ‘induction
period’.
• Under ordinary conditions, the induction period may take months or years.
• However, once a trace of peroxide is formed, further oxidation is
autocatalytic and proceeds very rapidly.
• Oxidation results in the formation of aldehydes and organic acids, which
impart taste and odor.
• Stabilizers may be added to retard oxidation
• Mineral oil may be sterilized by dry heat.
• Mineral oil should be stored in an airtight container, protected from light,
in a cool, dry place.

Incompatibilities
• Incompatible with strong oxidizing agents.

• Mineral oil is obtained by distillation of petroleum.
• The lighter hydrocarbons are first removed by distillation and the
residue is then redistilled between 330–390 °C.
• The distillate is chilled and the solid fractions are removed by
filtration.
• The filtrate is then further purified and decolorized by high-pressure
hydrogenation or sulfuric acid treatment; the purified filtrate is then
filtered through adsorbents.
• The liquid portion obtained is distilled and the portion boiling below
360 ° C is discarded.
• A suitable stabilizer may be added to the mineral oil

Safety
• Mineral oil is used as an excipient in a wide variety of pharmaceutical
formulations;
• Chronic oral consumption of mineral oil may impair the appetite and
interfere with the absorption of fat-soluble vitamins.
• Prolonged use should be avoided
• Regulatory Status: GRAS listed.

Functional Category
• Ointment base;
• stiffening agent.

Technology
• Paraffin is mainly used in topical pharmaceutical formulations as a
component of creams and ointments.
• In ointments, it may be used to increase the melting point of a
formulation or to add stiffness.
• Paraffin is additionally used as a coating agent for capsules and
tablets, and is used in some food applications.

Properties
• Solubility: Soluble in chloroform, ether, volatile oils, and most warm
fixed oils; slightly soluble in ethanol;
• Practically insoluble in acetone, ethanol (95%), and water.

• Paraffin is manufactured by the distillation of crude petroleum or
shale oil, followed by purification by acid treatment and filtration

Safety
• Paraffin is generally regarded as an essentially nontoxic and
nonirritant material when used in topical ointments and as a coating
agent for tablets and capsules
• Regulatory Status: Accepted in the UK for use in certain food
application

Synonym and Chemical Name
• Synonym: Yellow Soft Paraffin
• Chemical Name: Petrolatum

Description
• Petrolatum is a pale yellow to yellow-colored, translucent, soft
unctuous mass.
• It is odorless, tasteless, and not more than slightly fluorescent by
daylight, even when melted

Functional Category and Pharmaceutical
application in Formulation
• Emollient; ointment base.
• Applications in Petrolatum is mainly used in topical pharmaceutical
formulations as an emollient-ointment base; it is poorly absorbed by
the skin.
• Petrolatum is also used in creams and transdermal formulations and
as an ingredient in lubricant formulations for medicated
confectionery together with mineral oil.

Safety
• Petrolatum is mainly used in topical pharmaceutical formulations and
is generally considered to be a nonirritant and nontoxic material
• Regulatory status: GRAS listed..

Chemical Name and Synonyms
• Chemical Name: Sulfuric acid monododecyl ester sodium salt
• Synonyms: Dodecyl alcohol hydrogen sulfate

Description
• Sodium lauryl sulfate consists of white or cream to pale yellow
colored crystals, flakes, or powder having a smooth feel, a soapy,
bitter taste, and a faint odor of fatty substances.

Functional Category
• Anionic surfactant
• Detergent
• Skin penetrant (Permeation enhancer)
• Tablet and capsule lubricant
• Wetting agent

Technology
• Sodium lauryl sulfate is an anionic surfactant employed in a wide
range of non-parenteral pharmaceutical formulations and cosmetics;
• It is a detergent and wetting agent effective in both alkaline and acidic
conditions.
• In recent years it has found application in analytical electrophoretic
techniques:
• more widely used techniques for the analysis of proteins;
• Detergent in medicated shampoos (concentration 10%)
• Tablet lubricant (1.0–2.0%)

Properties
• Critical micelle concentration 8.2 mmol/L (2.365 g/L) at 208C
• Density 1.07 g/cm3 at 20°C
• HLB value 40

• Sodium lauryl sulfate is stable under normal storage conditions.
• However, in solution, under extreme conditions, i.e. pH 2.5 or below,
it undergoes hydrolysis to lauryl alcohol and sodium bi-sulfate.
• The bulk material should be stored in a well-closed container away
from strong oxidizing agents in a cool, dry place.

Incompatibilities
• Sodium lauryl sulfate reacts with cationic surfactants, causing loss of
activity even in concentrations too low to cause precipitation.
• Unlike soaps, it is compatible with dilute acids and calcium and
magnesium ions.
• Sodium lauryl sulfate is incompatible with salts of polyvalent metal
ions, such as aluminum, lead, tin or zinc, and precipitates with
potassium salts.
• Solutions of sodium lauryl sulfate (pH 9.5–10.0) are mildly corrosive
to mild steel, copper, brass, bronze, and aluminum.

• Sodium lauryl sulfate is prepared by sulfation of lauryl alcohol,
followed by neutralization with sodium carbonate

Safety
• Sodium lauryl sulfate is widely used in cosmetics and oral and topical
pharmaceutical formulations.
• It is a moderately toxic material with acute toxic effects including
irritation to the skin, eyes, mucous membranes, upper respiratory
tract, and stomach.
• Repeated, prolonged exposure to dilute solutions may cause drying
• and cracking of the skin; contact dermatitis may develop.
• Prolonged inhalation of sodium lauryl sulfate will damage the lungs
• Regulatory Status: GRAS listed

Description
• Peanut oil is a colorless or pale yellow-colored liquid that has a faint
nutty odor and a bland, nutty taste. At about 3°C it becomes cloudy,
and at lower temperatures it partially solidifies.

• A typical analysis of refined peanut oil indicates the composition of
the acids present as glycerides to be: arachidic acid 2.4%; behenic
acid 3.1%; palmitic acid 8.3%; stearic acid 3.1%; lignoceric acid 1.1%;
linoleic acid 26.0%, and oleic acid 56.0%.

Functional Category
• Oleaginous vehicle
• Solvent

Technology
• Peanut oil is used as an excipient in pharmaceutical formulations primarily as a
solvent for sustained-release intramuscular injections.
• It is also used as a vehicle for topical preparations and as a solvent for vitamins
and hormones.
• In addition, it has been part of sustained-release bead formulations, nasal drug
delivery systems, and controlled-release injectables.
• Therapeutically, emulsions containing peanut oil have been used in nutrition
regimens, in enemas as a fecal softener, and in otic drops to soften ear wax.
• It is also administered orally, usually with sorbitol, as a gall bladder evacuant
prior to cholecystography.
• Peanut oil is also widely used as an edible oil.

• Peanut oil is an essentially stable material. However on exposure to
air it can slowly thicken and may become rancid.
• Solidified peanut oil should be completely melted and mixed before
use.
• Peanut oil may be sterilized by aseptic filtration or by dry heat, for
example, by maintaining it at 150°C for 1 hour.
• Peanut oil should be stored in a well-filled, airtight, light resistant
container, at a temperature not exceeding 40°C.
• Material intended for use in parenteral dosage forms should be
stored in a glass container.

Source & Method of Manufacture
• Refined peanut oil is obtained from the seeds of Arachis hypogaea
Linne (Fam. Leguminosae).
• The seeds are separated from the peanut shells and are expressed in
a powerful hydraulic press.
• The crude oil has a light yellow to light brown color, and is then
purified to make it suitable for food or pharmaceutical purposes.
• A suitable antioxidant may be added.

Incompatibilities
• Peanut oil may be saponified by alkali hydroxides.

Safety
• Peanut oil is mildly laxative at a dosage of 15–60mL orally or of 100–
500mL rectally as an enema
• Peanut oil is harmful if administered intravenously and it should not
be used in such formulations.
• Regulatory Status: Included in the FDA Inactive Ingredients Database
(IM injections, topical preparations, oral capsules, and vaginal
emulsions).

Description
• Hydrous lanolin is a pale yellow-colored, unctuous substance with a
faint characteristic odor.
• When melted by heating on a water bath, hydrous lanolin separates
into a clear oily layer and a clear water layer.

• The JP XV describes hydrous lanolin as a mixture of lanolin and 25–
30% w/w purified water.
• The PhEur 6.0 describes hydrous lanolin as a mixture of lanolin and
25% w/w purified water. The PhEur additionally permits the inclusion
of up to 150 ppm of butylated hydroxytoluene as an antioxidant.

Functional Category
• Ointment base

Technology
• Hydrous lanolin is widely used in topical pharmaceutical formulations
and cosmetics in applications similar to those for lanolin.
• Hydrous lanolin is commonly used in the preparation of w/o creams
and ointments.
• More water may be incorporated into hydrous lanolin than into
lanolin

• Lanolin is melted, and sufficient purified water is gradually added
with constant stirring

Safety
• Hydrous lanolin is used in cosmetics and a number of topical
pharmaceutical formulations and is generally regarded as a nontoxic
and nonirritant material, although it has been associated with
hypersensitivity reactions
• Regulatory Status: Included in the FDA Inactive Ingredients Database
(ophthalmic, topical, transdermal, and vaginal preparations). Included
in nonparenteral medicines licensed in the UK.

References
Rowe, R. C., Sheskey, P. J., & Owen, S. C. (Eds.)Handbook
of pharmaceutical excipients (6th ed.). London:
Pharmaceutical Press and A.A.P.S., 2009
Lachman, L., Lieberman, H. A., & Kanig, J. L.. The Theory
and Practice of Industrial Pharmacy (3rd ed.). Mumbai:
Varghese Publishing House. ,1991.

Study of some common conventional excipients

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Study of some common conventional excipients

Similar to Study of some common conventional excipients (20)

More from Mirza Salman Baig

More from Mirza Salman Baig (20)

Recently uploaded

Recently uploaded (20)

Study of some common conventional excipients